VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,427,000 | -4.1% | 104,289 | -34.5% | 0.03% | -10.5% |
| Q1 2018 | $2,531,000 | +65.2% | 159,122 | +117.0% | 0.04% | +100.0% |
| Q4 2017 | $1,532,000 | +20.2% | 73,322 | -17.5% | 0.02% | +11.8% |
| Q3 2017 | $1,275,000 | -9.8% | 88,879 | +9.1% | 0.02% | 0.0% |
| Q2 2017 | $1,414,000 | +11.2% | 81,477 | -29.5% | 0.02% | +13.3% |
| Q1 2017 | $1,272,000 | +45.0% | 115,512 | +91.2% | 0.02% | +66.7% |
| Q4 2016 | $877,000 | +65.2% | 60,424 | +128.4% | 0.01% | +50.0% |
| Q2 2016 | $531,000 | -96.9% | 26,460 | -72.6% | 0.01% | -96.2% |
| Q3 2015 | $17,140,000 | +13.7% | 96,473 | +26.5% | 0.16% | +43.6% |
| Q1 2015 | $15,069,000 | -36.6% | 76,274 | -53.9% | 0.11% | -38.9% |
| Q4 2014 | $23,774,000 | -22.7% | 165,552 | -29.3% | 0.18% | -27.1% |
| Q3 2014 | $30,750,000 | +15.6% | 234,172 | +11.6% | 0.25% | +16.5% |
| Q2 2014 | $26,591,000 | -28.3% | 209,893 | -25.4% | 0.21% | -34.6% |
| Q1 2014 | $37,062,000 | -31.7% | 281,262 | -39.2% | 0.32% | -27.4% |
| Q4 2013 | $54,299,000 | -37.8% | 462,948 | -44.6% | 0.45% | -31.0% |
| Q3 2013 | $87,329,000 | +22.5% | 835,802 | +0.8% | 0.65% | +22.6% |
| Q2 2013 | $71,268,000 | – | 829,115 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |